Ladomery M - Search Results

1

Antonopoulou E, Ladomery M. Antonopoulou E, et al. Among authors: ladomery m. Int J Mol Sci. 2018 Apr 25;19(5):1287. doi: 10.3390/ijms19051287. Int J Mol Sci. 2018. PMID: 29693622 Free PMC article. Review.

2

Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm.

Ladomery MR, Harper SJ, Bates DO. Ladomery MR, et al. Cancer Lett. 2007 May 8;249(2):133-42. doi: 10.1016/j.canlet.2006.08.015. Epub 2006 Oct 5. Cancer Lett. 2007. PMID: 17027147 Review.

3

Role of splice variants in the metastatic progression of prostate cancer.

Hagen RM, Ladomery MR. Hagen RM, et al. Among authors: ladomery mr. Biochem Soc Trans. 2012 Aug;40(4):870-4. doi: 10.1042/BST20120026. Biochem Soc Trans. 2012. PMID: 22817750 Review.

4

Epigallocatechin-3-gallate promotes apoptosis and expression of the caspase 9a splice variant in PC3 prostate cancer cells.

Hagen RM, Chedea VS, Mintoff CP, Bowler E, Morse HR, Ladomery MR. Hagen RM, et al. Among authors: ladomery mr. Int J Oncol. 2013 Jul;43(1):194-200. doi: 10.3892/ijo.2013.1920. Epub 2013 Apr 24. Int J Oncol. 2013. PMID: 23615977

5

Aberrant alternative splicing is another hallmark of cancer.

Ladomery M. Ladomery M. Int J Cell Biol. 2013;2013:463786. doi: 10.1155/2013/463786. Epub 2013 Sep 11. Int J Cell Biol. 2013. PMID: 24101931 Free PMC article. Review.

6

Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance.

Hamdollah Zadeh MA, Amin EM, Hoareau-Aveilla C, Domingo E, Symonds KE, Ye X, Heesom KJ, Salmon A, D'Silva O, Betteridge KB, Williams AC, Kerr DJ, Salmon AH, Oltean S, Midgley RS, Ladomery MR, Harper SJ, Varey AH, Bates DO. Hamdollah Zadeh MA, et al. Among authors: ladomery mr. Mol Oncol. 2015 Jan;9(1):167-78. doi: 10.1016/j.molonc.2014.07.017. Epub 2014 Aug 20. Mol Oncol. 2015. PMID: 25224594 Free PMC article.

7

Quantitative analysis of ERG expression and its splice isoforms in formalin-fixed, paraffin-embedded prostate cancer samples: association with seminal vesicle invasion and biochemical recurrence.

Hagen RM, Adamo P, Karamat S, Oxley J, Aning JJ, Gillatt D, Persad R, Ladomery MR, Rhodes A. Hagen RM, et al. Among authors: ladomery mr. Am J Clin Pathol. 2014 Oct;142(4):533-40. doi: 10.1309/AJCPH88QHXARISUP. Am J Clin Pathol. 2014. PMID: 25239421

8

Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer.

Mavrou A, Brakspear K, Hamdollah-Zadeh M, Damodaran G, Babaei-Jadidi R, Oxley J, Gillatt DA, Ladomery MR, Harper SJ, Bates DO, Oltean S. Mavrou A, et al. Among authors: ladomery mr. Oncogene. 2015 Aug 13;34(33):4311-9. doi: 10.1038/onc.2014.360. Epub 2014 Nov 10. Oncogene. 2015. PMID: 25381816 Free PMC article.

9

The oncogene ERG: a key factor in prostate cancer.

Adamo P, Ladomery MR. Adamo P, et al. Among authors: ladomery mr. Oncogene. 2016 Jan 28;35(4):403-14. doi: 10.1038/onc.2015.109. Epub 2015 Apr 27. Oncogene. 2016. PMID: 25915839 Review.

10

Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.

Bowler E, Porazinski S, Uzor S, Thibault P, Durand M, Lapointe E, Rouschop KMA, Hancock J, Wilson I, Ladomery M. Bowler E, et al. Among authors: ladomery m. BMC Cancer. 2018 Apr 2;18(1):355. doi: 10.1186/s12885-018-4227-7. BMC Cancer. 2018. PMID: 29606096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page